Status:
COMPLETED
Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Collaborating Sponsors:
Caisse Primaire d'Assurance Maladie du Gard
Conditions:
Insulin Resistance
Hyperinsulinism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a two-center proof-of-concept study, ancillary to the MetACTIV study, whose objective is to define immune activation profiles from the data of individuals followed by the Caisse Primaire d'Ass...
Detailed Description
The local health insurance fund regularly offers people who have already had a free health check-up the opportunity to re-do a check-up. This invitation will be made as part of the routine, by mail. P...
Eligibility Criteria
Inclusion
- Individuals who participated in the MetACTIV study.
- Profile 2 subgroup-specific inclusion criteria:
- MetACTIV study individual with a Profile 2.
- Persons who have given free informed consent.
- Persons who have signed the consent form.
- Persons affiliated to or benefiting from a health insurance plan.
- Adults (≥18 years of age).
Exclusion
- Persons participating in Category 1 research involving human subjects
- Persons in an exclusion period as determined by another study.
- Persons under court protection, guardianship or trusteeship.
- Persons who are incapable of giving consent.
- Persons for whom it is impossible to give clear information.
- Pregnant, parturient or breastfeeding woman.
Key Trial Info
Start Date :
June 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 5 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05329337
Start Date
June 27 2022
End Date
October 5 2023
Last Update
December 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire
Nîmes, Gard, France, 30000
2
Caisse Primaire d'Assurance Maladie du Gard
Nîmes, Gard, France, 3000